COMMUNIQUÉS West-GlobeNewswire

Novartis announces Lancet publication of pioneering study in migraine prevention showing efficacy of Aimovig® where other treatments have failed
23/10/2018
The LIBERTY trial is the first study of a CGRP-targeted therapy in a patient population where multiple preventive treatments had previously failed Patients treated with Aimovig, reported significant reductions in [...]
Chembio Announces Proposed Public Offering of Common Stock
22/10/2018
MEDFORD, N.Y., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio” or the “Company”), a leading point-of-care diagnostics company focused on infectious diseases, today announced that it [...]
INSYS Therapeutics to Report Third Quarter 2018 Results on Nov. 5
22/10/2018
PHOENIX, Oct. 22, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today announced [...]
National Research Corporation to Broadcast its 2018 Third Quarter Conference Call Live on the Internet
22/10/2018
Lincoln, Nebraska, Oct. 22, 2018 (GLOBE NEWSWIRE) -- National Research Corporation (NASDAQ/:NRC) today announced that it will provide an online web simulcast of its 2018 third quarter earnings conference call on [...]
ContraFect to Participate in World Antimicrobial Resistance Congress 2018
22/10/2018
YONKERS, N.Y., Oct. 22, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics for life- [...]
MacroGenics Announces Participation in Three Investor Conferences
22/10/2018
ROCKVILLE, MD, Oct. 22, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for [...]
NanoVibronix to Present at Dawson James Securities 4th Annual Small Cap Growth Conference
22/10/2018
ELMSFORD, N.Y., Oct. 22, 2018 (GLOBE NEWSWIRE) -- NanoVibronix, Inc., (NASDAQ: NAOV) , a medical device company utilizing the Company’s proprietary and patented low intensity surface acoustic wave (SAW) technology, [...]
Chembio Reports Preliminary Third Quarter 2018 Revenue
22/10/2018
Signs Definitive Agreement to Acquire opTricon GmbH MEDFORD, N.Y., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Chembio Diagnostics, Inc. (Nasdaq: CEMI) (“Chembio” or the “Company”), a leading point-of-care diagnostics company [...]
Osmotica Pharmaceuticals plc Announces Closing of Initial Public Offering
22/10/2018
BRIDGEWATER, N.J., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc, a fully integrated biopharmaceutical company, today announced the closing of its initial public offering of 7,647,500 ordinary shares at [...]
CLEARSIDE, XIPERE™ and PEACHTREE to be Front and Center at AAO 2018
22/10/2018
ALPHARETTA, Ga., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing treatments that restore and preserve vision for people with serious eye [...]
Harvard Bioscience Names Kam Unninayar as Chief Financial Officer
22/10/2018
Seasoned Financial Executive With More Than a Decade in Global Life Science Instrumentation, Will Begin on November 26 HOLLISTON, Mass., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “ [...]
Akcea Therapeutics to Hold Third Quarter 2018 Financial Results Webcast
22/10/2018
Webcast scheduled for Monday, November 5 th at 4:30 p.m. Eastern Time BOSTON, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics, Inc. (Nasdaq:AKCA), an affiliate of Ionis Pharmaceuticals, Inc., announced today that [...]
Aclaris Announces Closing of Public Offering of Common Stock
22/10/2018
WAYNE, Pa., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Aclaris Therapeutics, Inc. (Nasdaq: ACRS), a dermatologist-led, biopharmaceutical company focused on identifying, developing, and commercializing innovative therapies to [...]
Evolus Expands Leadership Team with Appointments of Key Executives
22/10/2018
Appoints Kurt Knab as Vice President, Sales Appoints Alejandro “Alex” Sabad as Vice President, Operations Appoints Amy Marinne Fox as Vice President, Human Resources IRVINE, Calif., Oct. 22, 2018 (GLOBE NEWSWIRE) -- [...]
Ovid Therapeutics Receives “Company Making a Difference Award” from CDKL5 Deficiency Disorder Community
22/10/2018
NEW YORK, Oct. 22, 2018 (GLOBE NEWSWIRE) -- Ovid Therapeutics Inc. (NASDAQ: OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today [...]
BIOPHYTIS : Interim Results 2018 and Perspective on Activity
22/10/2018
PARIS, Oct. 22, 2018 (GLOBE NEWSWIRE) -- BIOPHYTIS (Euronext Growth Paris: ALBPS), a biotechnology company specializing in the development of drug candidates to fight age-related degenerative diseases, announces the [...]
Marrone Bio Innovations Pest Management Products Win the International Biocontrol Manufacturers Association’s Bernard Blum Award for a Novel Biocontrol Solution
22/10/2018
DAVIS, Calif., Oct. 22, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (MBI) (NASDAQ: MBII), a leading global provider of bio-based pest management and plant health products, today announced that the [...]
Scientus Pharma Obtains Health Canada Approval for Cannabis Oils and Softgel Production
22/10/2018
TORONTO, Oct. 22, 2018 (GLOBE NEWSWIRE) -- HydRx Farms Ltd. (o/a Scientus Pharma) (“Scientus” or the “Company”), a biopharmaceutical company conducting research and product development for extracts and formulations [...]
POSITIVE TRIAL RESULTS WITH FILGOTINIB IN PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS BOTH PUBLISHED IN THE LANCET
22/10/2018
Phase 2 EQUATOR Data Demonstrating Efficacy in Psoriatic Arthritis Also Presented in a Plenary Session at 2018 ACR/ARHP Annual Meeting Chicago, October 22, 2018; 19.15 CET - Gilead Sciences, Inc. (Nasdaq: GILD) and [...]

Pages